Pharma in review: trending stories 10/11/19

Oct 11, 2019

number1

Glenmark receives FDA warning letter for Baddi plant

Mumbai-based Glenmark has been issued a FDA warning letter for manufacturing issues.


number2Pfizer inks antisense drug deal worth up to $1.5B
Pfizer will front $250 million to gain rights to a phase 2 drug.

number3Jury awards man $8B for claims a J&J drug made him grow breasts

A jury has ordered J& to pay $8 billion for a claim that the company failed to warn patients.

number4

Universities took millions in gifts from Sackler family

Universities around the world have accepted at least $60 million in donations over the past five years.

number5

How to find the right CDMO partner 

A couple of deciding factors remain constant industry-wide